This study was a randomised, controlled, double-blinded, multicenter clinical trial to investigate a high-protein, increased-fibre diet supplemented with omega-3 fatty acids, for dogs with cancer undergoing standard-of-care chemotherapy.
Since the intricate relationship between nutrition and cancer encompasses various aspects, this review therefore intends to cover the most important points in nutrition in canine and feline oncology.
Research suggests that dogs with cancer should eat a nutrient profile with 25-40% dry matter fat and 5% dry matter or greater of dietary omega-3 fatty acids. Omega-3 fatty acids have been shown to exert an anti-tumor effect. Obese dogs showed altered lipid and metabolic profiles and more aggressive tumors, suggesting an important relationship between dyslipidemia and tumor aggressiveness. Supplementation with fish oil, rich in omega-3 fatty acids, may alter metabolic parameters in cancer patients. By anticipating the nutritional impacts of cancer treatment, you can work with your family veterinarian and/or a qualified veterinary nutritionist to adjust your dogs nutrient profile and potentially avoid some negative side effects. Explanations for the beneficial effects of n-3 fatty acids other than alterations in the pharmacokinetics of chemotherapy drugs should be investigated. Dogs may metabolize drugs differently prior to remission of lymphoma than when in remission.
Furthermore, visual representations like the one above help us fully grasp the concept of Canine Cancer And The Importance Of Fatty Acid Profiles.
Explanations for the beneficial effects of n-3 fatty acids other than alterations in the pharmacokinetics of chemotherapy drugs should be investigated. Dogs may metabolize drugs differently prior to remission of lymphoma than when in remission.
This study was a randomized, controlled, double-blinded, multicenter clinical trial to investigate a high-protein, increased-fiber diet supplemented with omega-3 fatty acids, for dogs with cancer undergoing standard-of-care chemotherapy.
